Amydis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.amydis.com
A Study of AMDX-2011P in Participants With Alzheimer's Disease
- First Posted Date
- 2024-07-23
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Amydis Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT06514001
- Locations
- 🇺🇸
Global Research Management, Glendale, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Associated Retina Consultants, Phoenix, Arizona, United States
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
- First Posted Date
- 2024-01-25
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Amydis Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06223048
- Locations
- 🇺🇸
Associated Retina Consultants, Phoenix, Arizona, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Global Research Management, Glendale, California, United States
A Study of AMDX-2011P in Participants With CAA
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Amydis Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT05709314
- Locations
- 🇺🇸
Associated Retina Consultants, Phoenix, Arizona, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Global Research Management, Glendale, California, United States
AMDX-2011P Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Phase 1
Recruiting
- Conditions
- Amyotrophic Lateral SclerosisParkinson Disease
- Interventions
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Amydis Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05542576
- Locations
- 🇺🇸
Eye Research Foundation, Newport Beach, California, United States
🇺🇸Brittany NIcholl, Pasadena, California, United States
© Copyright 2025. All Rights Reserved by MedPath